Update on China NMPA & US FDA Emergency Approval – Implications to Life Science Companies Relating to COVID-19

Update on China NMPA & US FDA Emergency Approval – Implications to Life Science Companies Relating to COVID-19

  • Version
  • Watch 22
  • File Size 0.00 KB
  • File Count 1
  • Create Date May 8, 2020
  • Last Updated May 8, 2020